ArteraAI Prostate Test

Categories

Description

AI-powered test for personalized prostate cancer therapy decisions.

Summary

ArteraAI Prostate Test leverages multimodal artificial intelligence (MMAI) to provide predictive and prognostic cancer tests, enabling personalized treatment decision-making for prostate cancer. It is the first AI test recommended in the NCCN Guidelines for Prostate Cancer for its predictive performance, offering a novel approach to cancer therapy personalization.

Use Cases

• Identifying patients who will benefit from therapy intensification for localized prostate cancer.
• Guiding treatment decisions by predicting therapy benefit and determining prognosis.